NewYork-Presbyterian Hospital is No. 6 in the country and No. 1 in New York in this year’s U.S. News & World Report’s hospital ranking.
Columbia is part of a new consortium to identify rare genetic variants that may protect against, or contribute to Alzheimer’s disease.
A new study measures the risk of developing Parkinson’s for people with Gaucher disease and Gaucher carriers.
Columbia researchers have taken a significant step forward toward deciphering the genetics of schizophrenia, which could have important implications for early detection of the condition.
A study of long-acting injectable antipsychotics for people with schizophrenia found that newer medication was no more effective than older, less expensive medication.
Recent research at Columbia has shed light on an important risk marker for Alzheimer’s—”white matter hyperintensities” (WMH).